NDC 68071-4355-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-4355
- Requested NDC
- 68071-4355-01
- Package NDCs from labels
- 68071-4355-4, 68071-4355-3, 68071-4355-7, 68071-4355-1, 68071-4355-8, 68071-4355-9, 68071-4355-2, 68071-4355-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-10-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2026-10-28 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4355-1 | Cephalexin | 21 in 1 BOTTLE | CAPSULE | 21 | 10 | |
| 68071-4355-3 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 10 | |
| 68071-4355-4 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 10 | |
| 68071-4355-7 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 10 | |
| 68071-4355-8 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 10 | |
| 68071-4355-9 | Cephalexin | 10 in 1 BOTTLE | CAPSULE | 10 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4355 | CEPHALEXIN CAPSULE [NUCARE PHARMACEUTICALS,INC.] | 10 | Current NDC, Legacy NDC, 6 package rows | 20240608_681c235f-6dee-1401-e053-2991aa0addc0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68071-4355-7 | EA - Each | 68071-4355 | fbeb737c-181b-4ead-a970-870d22983ef3 | 1 | 2021-04-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Fair Light | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | 6377c0f7-e2cb-44f0-9786-42c5a9d02f88 | 2024-08-04 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Light | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | e98696d2-7f7f-4a4c-b8ae-849f2d211a04 | 2024-08-04 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Medium Deep | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | f31842f7-3474-4462-87e2-c4ebde97a583 | 2024-08-04 | Warnings | 15FIX9V2JP |
| JUNGSAEMMOOL Essential Skin Nuder Longwear Cushion Medium | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, OCTISALATE | Jungsaemmool Beauty Co., Ltd. | ccfafefc-fff4-41ff-baf4-3f430c690be7 | 2024-08-04 | Warnings | 15FIX9V2JP |
| Cephalexin | CEPHALEXIN | Proficient Rx LP | e43271ef-c145-4145-b7f0-a02c237de2b5 | 2024-08-02 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Mind Detox and Drainage | ALUMINA, BARYTA CARBONICA, CARBONEUM SULPHURATUM, CEREBRUM SUIS, CONIUM MACULATUM, HELLEBORUS NIGER, LECITHIN, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, MERCURIUS SOLUBILIS, NAJA TRIPUDIANS, PICRICUM ACIDUM, PLATINUM METALLICUM, SILICEA, STRAMONIUM, SULPHURICUM ACIDUM, ZINCUM PHOSPHORATUM | Deseret Biologicals, Inc. | 1ac1e955-a374-4cac-b997-51c6aef8d35d | 2024-08-01 | Warnings | ETJ7Z6XBU4 |
| Essential Sheer SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 2132dc18-85ee-4449-86d2-d9f698f286c6 | 2024-07-31 | Warnings | 15FIX9V2JP |
| Proceuticals Private Label by TiZO tinted foaming mineral sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, Ltd | 1e78109f-4d2e-2705-e063-6294a90a5ad3 | 2024-07-30 | Warnings | 15FIX9V2JP |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 28fec572-e3b9-448c-8626-5c0920f38eeb | 2024-07-30 | Warnings, Adverse reactions | OBN7UDS42Y |
| Replenix Sheer SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 37d1f454-3bc9-4ce5-863c-0d4f6fa18fb4 | 2024-07-29 | Warnings | 15FIX9V2JP |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | df6bb893-e3d7-4c8f-8cec-35b4d2fa33b3 | 2024-07-26 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f4ced8c7-a276-4a44-a60c-f8d1689a2bdf | 2024-07-26 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6e5f9616-ddf2-19c4-e053-2991aa0a372a | 2024-07-18 | Warnings, Adverse reactions | ANDA090836 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ada33464-b416-9ac6-e053-2a95a90af787 | 2024-07-17 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | ade02343-3e4b-b1f1-e053-2995a90ac5fe | 2024-07-17 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | a33280d4-7caf-f74b-e053-2a95a90a90c3 | 2024-07-17 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Asclemed USA, Inc | 945552cb-90e4-41fb-afe2-8ee8785e94da | 2024-07-17 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Derma E Sun Defense Face SPF 30 | ZINC OXIDE TITANIUM DIOXIDE | derma e | d90b8f81-de7a-4022-800a-90f063e94180 | 2024-07-17 | Warnings | 15FIX9V2JP |
| PROCEUTICALS PRIVATE LABEL by TiZO mineral lip sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD | 1d611494-648b-6e5f-e063-6294a90a4500 | 2024-07-16 | Warnings | 15FIX9V2JP |
| SkinCeuticals Physical Fusion UV Defense Broad Spectrum SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | L'Oreal USA Products Inc | 8df98d97-a5d2-4d52-8bd2-130a13501d60 | 2024-07-16 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.